We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

47 hedge funds and large institutions have $27.9M invested in Tempest Therapeutics in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 11

11% less capital invested

Capital invested by funds: $31.3M → $27.9M (-$3.41M)

13% less funds holding

Funds holding: 54 → 47 (-7)

20% less call options, than puts

Call options by funds: $4K | Put options by funds: $5K

55% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 11

Holders
47
Holders Change
-7
Holders Change %
-12.96%
% of All Funds
1.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
12
Reduced
11
Closed
11
Calls
$4K
Puts
$5K
Net Calls
-$1K
Net Calls Change
-$2K

Top Buyers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
+$1.18M
2
GC
GMT Capital
Georgia
+$1.17M
3
BC
Broadfin Capital
New York
+$402K
4
DMK
David M. Knott
+$180K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$120K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.96M
2
Legal & General Group
Legal & General Group
United Kingdom
-$713K
3
ECM
Element Capital Management
New York
-$188K
4
PP
Paloma Partners
Connecticut
-$180K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$176K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$83K +$68.4K +16 +400%
OC
27
Oppenheimer & Co
New York
$72K +$17.1K +4 +29%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$48K – – –
Janus Henderson Group
29
Janus Henderson Group
United Kingdom
$45K – – –
SKK
30
Shepherd Kaplan Krochuk
Massachusetts
$45K +$25.6K +6 +120%
Morgan Stanley
31
Morgan Stanley
New York
$41K -$111K -26 -72%
California Public Employees Retirement System
32
California Public Employees Retirement System
California
$38K – – –
State Street
33
State Street
Massachusetts
$30K -$12.8K -3 -30%
ECM
34
Element Capital Management
New York
$21K -$188K -44 -90%
GC
35
Guggenheim Capital
Illinois
$19K – – –
Renaissance Technologies
36
Renaissance Technologies
New York
$17K +$17.1K +4 New
Dimensional Fund Advisors
37
Dimensional Fund Advisors
Texas
$16K -$8.55K -2 -33%
SIP
38
Stoneridge Investment Partners
Pennsylvania
$16K – – –
UBS Group
39
UBS Group
Switzerland
$12K +$8.55K +2 +200%
Deutsche Bank
40
Deutsche Bank
Germany
$9K – – –
Citigroup
41
Citigroup
New York
$8K -$4.28K -1 -33%
MAM
42
Meeder Asset Management
Ohio
$7K +$8.55K +2 New
MA
43
MUFG Americas
New York
$6K – – –
TIM
44
Tortoise Investment Management
New York
$5K – – –
Federated Hermes
45
Federated Hermes
Pennsylvania
$4K – – –
TRCT
46
Tower Research Capital (TRC)
New York
$4K +$4.28K +1 New
Bank of America
47
Bank of America
North Carolina
$2K -$17.1K -4 Closed
BWM
48
Baystate Wealth Management
Massachusetts
$2K – – –
TCOV
49
Trust Company of Vermont
Vermont
$2K – – –
Bank of Montreal
50
Bank of Montreal
Ontario, Canada
$1K – – –
1
2
3

TPST Hedge Fund Activity: Q3 2017 in Review

47 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q3 2017, worth a combined $27.9M — down 11% from $31.3M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of TPST and 5 opened new positions — a net loss of 6 holders — while 11 trimmed existing stakes and 12 added.

The largest buyer was Avoro Capital Advisors, adding an estimated $1.18M. The largest seller was Fidelity Investments, cutting an estimated $1.96M.

  • 47 institutional investors held Tempest Therapeutics (TPST) as of Q3 2017, down from 54 in Q2 2017.
  • Funds reported $27.9M of Tempest Therapeutics stock for Q3 2017, down 11% quarter-over-quarter.
  • 5 funds opened new Tempest Therapeutics positions in Q3 2017 and 11 closed out, a net change of -6 holders.
  • The largest Tempest Therapeutics buyer in Q3 2017 was Avoro Capital Advisors, an estimated $1.18M added.
  • The largest Tempest Therapeutics seller in Q3 2017 was Fidelity Investments, an estimated $1.96M sold.

Based on aggregated 13F filings for Q3 2017.